Navigation Links
Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni-body Internal Skeleton
Date:8/18/2009

PALO ALTO, Calif., Aug. 18 /PRNewswire/ -- Nfocus Neuromedical Inc. announced today that the Food & Drug Administration has cleared its novel guiding catheter, the Echo(TM) Distal Access Guiding Catheter, for marketing in the US.

"Nfocus works closely with key clinical opinion leaders to direct all of our design and development projects, and the Echo is our latest success story," said President and CEO Martin Dieck. "Our advisors identified the need for a guiding catheter with improved performance and our team has responded with Echo."

The Echo(TM) Distal Access Guiding Catheter has been cleared by the FDA for introduction of interventional and/or diagnostic devices in peripheral, coronary and neurovascular vessels. A high-quality guiding catheter is required in today's advanced and complex endovascular procedures to assist in reaching the target vessel with stents and other operative devices. The guiding catheter must be atraumatic and flexible within the distant and smaller target vessel - yet provide stable and firm support in the larger vessels where the device enters the body.

"The Echo is a stable platform for placing today's most advanced interventional devices and its unique construction gives it the ability to maintain a round lumen to enable endovascular procedures in very far-reaching vessel locations," continued Mr. Dieck.

"Combined with Echo's earlier CE Mark approval, the US FDA clearance gives Nfocus the ability to enter the top end of interventional guiding catheter markets worldwide. Endovascular surgeons and interventional neuroradiologists will appreciate the supple distal end which resists ovalizing of the lumen and the exceptional support of the proximal section - both produced by the unique catheter skeleton."

About Nfocus Neuromedical Inc.

Nfocus is positioning itself to be the world-wide leader in the development of next-generation endovascular neurosurgery solutions (surgery through less-invasive catheter devices) . Backed by premier venture investors, the Company is developing revolutionary systems to treat neurovascular disease - including brain aneurysms - which are simple, safe, cost-effective and curative.

To learn more about the Nfocus Neuromedical development programs focused on providing faster, simpler and more permanent treatment of vascular diseases of the brain and spine, please visit the Nfocus website: www.nfocusneuro.com.

For more information about aneurysms and hemorrhagic stroke see: www.strokeassociation.org and www.snisonline.org


'/>"/>
SOURCE Nfocus Neuromedical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
2. Nfocus Neuromedical Announces Acquisition of StarFire Medical
3. Nfocus Neuromedical Elects Eric P. Milledge Chairman of Board
4. National Healthcare Providers Select onFocus epm(TM) To Help Ensure Success on Financial and Strategic Objectives
5. Nfocus Neuromedical Announces European Approval for Novel Guiding Catheter at Society of NeuroInterventional Surgery
6. Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... CA (PRWEB) , ... August 21, 2017 , ... The ... how exactly are we supposed to get things done in a healthy way these ... And, they’re launching a crowdfunding campaign on August 28 to introduce Deskcise Pro™– the ...
(Date:8/21/2017)... ... 2017 , ... The American Hospital Association (AHA) has elected Claire Zangerle, Chief ... its Board of Trustees for a three-year term beginning January 1, 2018. , ... individuals that are committed to the improvement of health in their communities. Founded in ...
(Date:8/21/2017)... Los Angeles, CA (PRWEB) , ... August 21, ... ... Optum, the health services business of UnitedHealth Group (NYSE: UNH), has made a ... and first responders affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries ...
(Date:8/20/2017)... ... ... A total solar eclipse will occur across the U.S. on Monday, August 21, ... the sun and Earth. This rare event will be magnificent to witness, but what does ... on the road during the total eclipse of the sun. , 1. Plan ahead. The ...
(Date:8/20/2017)... ... ... State Farm Neighborhood Assist® has named The Southern Maryland Team Anti-Bullying Program ... initiative wins, Gals Lead – Dream Queen Foundation’s signature teen girl program to help ... Calvert and Charles Counties. The program could potentially impact nearly 17,500 female students (49.4 ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... and big data solutions, announced today that it ... non-U.S. investors for the sale of shares of ... Company,s newly designated Series B Convertible Preferred Stock ... to conduct a closing with respect to the ...
(Date:8/15/2017)... 15, 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), ... Michigan residents. Naloxone is available ... retail pharmacy, G-3320 Beecher Road. ... and Drug Administration, is intended to block or reverse ... and loss of consciousness. The medication is often carried ...
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that ... Therapy Inc., has recently opened a New York City Office in ... usage of its unique Topical Wound Oxygen (TWO 2 ) homecare ... the Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS ... ...
Breaking Medicine Technology: